Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for reduction of periprosthetic bone resorption after total knee arthroplasty
2010-023193-39Phase 4Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Aseptic loosening (AL) comparing Zoledronic acid with Placebo (2 arms). Primary endpoint: Periprosthetic bone densitometry. Started Jan 2011; status: active.
02
Drugs
zoledronic acid
03
Conditions
Aseptic loosening (AL)
Beyond the preview
Go deeper on 2010-023193-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023193-39.